RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MONTESARCHIO V
Collezione AO Ordine Mauriziano

Items : 9

Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial. in International journal of cancer / Int J Cancer. 2023 Oct 15;153(8):1520-1528. doi: 10.1002/ijc.34632. Epub 2023 Jun 30.

2023
AO Ordine Mauriziano

Napolitano S; Ciardiello D; De Falco V; Martini G; Martinelli E; Della Corte CM; Esposito L; Famiglietti V; Di Liello A; Avallone A; Cardone C; De Stefano A; Montesarchio V; Zampino MG; Fazio N; Di Maio M; Del Tufo S; De Vita F; Altucci L; Marrone F; Ciardiello F; Troiani T;

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis. in iScience / iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17.

2023
AO Ordine Mauriziano

Anpalakhan S; Signori A; Cortellini A; Verzoni E; Giusti R; Aprile G; Ermacora P; Catino A; Pipitone S; Di Napoli M; Scotti V; Mazzoni F; Guglielmini PF; Veccia A; Maruzzo M; Schinzari G; Casadei C; Grossi F; Rizzo M; Montesarchio V; Verderame F; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Tondini CA; Camerini A; Banzi MC; et alii...

Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2023 Jul 1;9(7):966-970. doi: 10.1001/jamaoncol.2023.0655.

2023
AO Ordine Mauriziano

Napolitano S; De Falco V; Martini G; Ciardiello D; Martinelli E; Della Corte CM; Esposito L; Famiglietti V; Di Liello A; Avallone A; Cardone C; De Stefano A; Montesarchio V; Zampino MG; Bordonaro R; Scartozzi M; Santini D; Di Maio M; De Vita F; Altucci L; Marrone F; Ciardiello F; Troiani T;

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul.

2023
AO Ordine Mauriziano

Bersanelli M; Verzoni E; Cortellini A; Giusti R; Calvetti L; Ermacora P; Di Napoli M; Catino A; Guadalupi V; Guaitoli G; Scotti V; Mazzoni F; Veccia A; Guglielmini PF; Perrone F; Maruzzo M; Rossi E; Casadei C; Montesarchio V; Grossi F; Rizzo M; Travagliato Liboria MG; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Camerini A; Sorarù M; et alii...

Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients. in ESMO open / ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5.

2023
AO Ordine Mauriziano

Arenare L; Porta C; Barberio D; Terzolo S; Zagonel V; Pisconti S; Del Mastro L; Pinto C; Bilancia D; Cinieri S; Rizzo M; Migliaccio G; Montesarchio V; Del Campo L; De Lorenzo F; Iannelli E; Traclò F; Gitto L; Vaccaro MC; Frontini L; Giannarelli D; Bryce J; Piccirillo MC; Jommi C; Efficace F; Riva S; Di Maio M; Gallo C; Perrone F; et alii...

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. in BMJ open / BMJ Open. 2021 Oct 20;11(10):e049128. doi: 10.1136/bmjopen-2021-049128.

2021
AO Ordine Mauriziano

Cogoni AA; Zagonel V; Del Mastro L; Porta C; Cinieri S; Barberio D; Vaccaro CM; Jommi C; Gitto L; Traclò F; Iannelli E; De Lorenzo F; Del Campo L; Bryce J; Giannarelli D; Frontini L; Montesarchio V; Efficace F; Di Maio M; Arenare L; Riva S; Bordonaro R; Gimigliano A; Piccirillo MC; Guizzaro L; Gallo C; Perrone F;

A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jun;29(6):3219-3233. doi: 10.1007/s00520-020-05840-z. Epub 2020 Oct 22.

2021
AO Ordine Mauriziano

Piccirillo MC; Sparavigna L; Savio A; Romano F; Gimigliano A; Canzanella G; Arenare L; Vaccaro CM; Traclò F; Montesarchio V; Jommi C; Iannelli E; Gitto L; Giannarelli D; Frontini L; De Lorenzo F; Bryce J; Del Campo L; Di Maio M; Riva S; Efficace F; Guizzaro L; Gallo C; Perrone F;

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Dicorato AM; Verusio C; Giordano P; Gernone A; Prati V; Carnio S; Corbo C; Tassinari D; Cavanna L; Meriggi F; Iannopollo M; Sartori D; Longo L; Pezzuolo D; Bonetti A; Mucciarini C; Bracarda S; Fornarini G; Battelli N; Russo A; Lacidogna G; Zucali PA; Sorarù M; Banzi M; Negrini G; Cinieri S; Fratino L; Zustovich F; Mencoboni M; et alii...

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol. in BMJ open / BMJ Open. 2019 Sep 9;9(9):e031485. doi: 10.1136/bmjopen-2019-031485.

2019
AO Ordine Mauriziano

Riva S; Bryce J; De Lorenzo F; Del Campo L; Di Maio M; Efficace F; Frontini L; Giannarelli D; Gitto L; Iannelli E; Jommi C; Montesarchio V; Traclò F; Vaccaro CM; Gallo C; Perrone F;